Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
Rosacea is a skin condition that affects the face, specifically the forehead, nose, cheeks, and chin.1,2 Patients often require...
COVID-19 is a severe acute respiratory syndrome that has blighted the world over the last year. The World Health...
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
For several years we have approached a ‘standard of care’ (SOC) for the treatment of metastatic HER2-positive breast cancer....
The field of immunology is transforming the landscape for cancer patients. When you can get a T-cell into the...
Despite years of research, cancer metastasis always remains incurable and fatal. There are no approved drugs for the prevention...
Flow cytometry is a technique in which tens of thousands of cells are passed through a fluidics system, and...
Lung cancer is the number one cause of cancer-related death worldwide. Each year, about 2.2 million new cases of...